See how RELiZORB works Skip to content

See how RELiZORB works

The only FDA-cleared enzyme product to break down fats in enteral formula

The only FDA-cleared enzyme product to break down fats in enteral formula

cartridge

RELiZORB is the only FDA-cleared enzyme product to break down fats in enteral formula

RELiZORB is a digestive enzyme cartridge that contains the enzyme lipase and is used with enteral nutrition to break down fats. RELiZORB mimics the function of the digestive pancreatic enzyme lipase by covalently binding lipase to small white beads inside the RELiZORB cartridge, called iLipase®. RELiZORB allows for the delivery of absorbable fatty acids and monoglycerides by hydrolyzing fats from enteral formulas prior to ingestion by the patient. Similar to human pancreatic lipase, the iLipase in RELiZORB is intended to selectively break apart triglycerides at the sn-1 and sn-3 positions and is not derived from a porcine or animal source.

iLipase®

The digestive enzyme lipase is attached to polymeric microbead carriers and is stored within the RELiZORB cartridge without being ingested.

Cartridge diagram

RELiZORB connects directly to your patient’s feeding tube

RELiZORB connected to a feeding tube

Inside the RELiZORB cartridge is a digestive enzyme called lipase, which is attached to the small white beads that you can see through the clear cartridge.

As the enteral formula passes through RELiZORB, it makes contact with the lipase-enzyme bead combination (called iLipase), and the fat in the formula is broken down to its absorbable form (called fatty acids and monoglycerides).

Fats in their absorbable form (fatty acids and monoglycerides) leave the RELiZORB cartridge and enter your patient’s body, while the iLipase remains in the cartridge.